ABILIFY MAINTENA Trademark

Trademark Overview

On Wednesday, August 17, 2011, a trademark application was filed for ABILIFY MAINTENA with the United States Patent and Trademark Office. The USPTO has given the ABILIFY MAINTENA trademark a serial number of 85400584. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 8, 2022. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The ABILIFY MAINTENA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
abilify maintena

General Information

Serial Number85400584
Word MarkABILIFY MAINTENA
Filing DateWednesday, August 17, 2011
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 8, 2022
Registration Number4236167
Registration DateTuesday, November 6, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 22, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo 101-8535
JP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo
JP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo
JP

Trademark Events

Event DateEvent Description
Thursday, December 8, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, December 8, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, December 8, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, December 6, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 23, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, November 6, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, August 4, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 3, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 3, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 26, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, November 6, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 6, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 13, 2012NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 26, 2012ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, June 26, 201244(e) PETITION - GRANTED
Thursday, June 21, 2012ASSIGNED TO PETITION STAFF
Monday, June 11, 2012TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, March 13, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2011ASSIGNED TO EXAMINER
Monday, August 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 20, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

maintena abilify system diseases disorders nervous central preparations treatment pharmaceutical